BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 30, 1998
View Archived Issues
Zaleplon shows advantage over zolpidem for sleep disorders in phase III
Read More
U.S. patent licensed to Avax Technologies issued for anticancer compounds
Read More
Company Profile: Pacific Pharmaceuticals
Read More
Corixa to acquire GenQuest
Read More
Phase II retreatment trial with Bexxar commences
Read More
Oxidized phenolic compounds with an unexpected mechanism of action
Read More
TX-525, a potent synthetic progestin with low androgenic potential
Read More
European trial of Bextra initiated
Read More
5alpha-Reductase inhibitor from Merck with potential in treating acne
Read More
Rhone-Poulenc Rorer seeks FDA approval for CFC-free Intal Inhaler
Read More
Parke-Davis discusses development of potent, irreversible EGF receptor TK inhibitors
Read More
University of British Columbia awarded grant to study vanadium compounds
Read More
Regulatory approval sought for lamivudine in U.S. for treatment of hepatitis B
Read More
Inhibitors of Ras function patented by Schering-Plough
Read More
Early studies with JE-2147 yield promising results
Read More
Boehringer Ingelheim presents new leukotriene antagonists
Read More
Factor Xa inhibitors developed by Boehringer Mannheim researchers
Read More
Astra devotes significant resources to development of immunomodulatory peptides
Read More
Termination of Gilead-Glaxo Wellcome code blocker collaboration
Read More
Hydroxyurea in combination regimens enhances anti-HIV activity
Read More
First launch for Bayer's miglitol
Read More
U.K. introduction for Viracept
Read More
Fujisawa scientists identify potent, nonpeptide bradykinin antagonist
Read More
No dose-limiting toxicity found yet for AN-9 in phase I
Read More
DPPE proves highly effective and well tolerated in metastatic breast cancer patients
Read More
Agouron in-licenses S-1153; phase I results presented at AIDS conference
Read More
